A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-Negative HER2-Overexpressed Breast Cancer
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2015.09.009
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Elsevier BV